Hubei Hongyuan Pharmaceutical Technology Co., Ltd. (SHE:301246)
China flag China · Delayed Price · Currency is CNY
15.65
-0.45 (-2.80%)
At close: Jul 4, 2025, 2:57 PM CST

SHE:301246 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jul '25 Dec '24 Dec '23 Jan '23 Jan '22 Jan '21 2015 - 2019
6,2105,38510,392---
Upgrade
Market Cap Growth
-20.86%-48.18%----
Upgrade
Enterprise Value
5,0704,0688,758---
Upgrade
Last Close Price
15.6513.5025.83---
Upgrade
PE Ratio
213.57104.64119.22---
Upgrade
PS Ratio
3.493.045.06---
Upgrade
PB Ratio
1.431.242.38---
Upgrade
P/TBV Ratio
1.491.292.49---
Upgrade
P/OCF Ratio
--294.81---
Upgrade
EV/Sales Ratio
2.852.304.26---
Upgrade
EV/EBITDA Ratio
25.1419.1039.79---
Upgrade
EV/EBIT Ratio
286.39115.30136.98---
Upgrade
Debt / Equity Ratio
0.110.090.080.210.050.13
Upgrade
Debt / EBITDA Ratio
2.381.751.581.240.180.37
Upgrade
Debt / FCF Ratio
-----1.85
Upgrade
Asset Turnover
0.310.310.430.650.750.77
Upgrade
Inventory Turnover
6.266.886.674.402.892.57
Upgrade
Quick Ratio
1.962.353.200.931.011.15
Upgrade
Current Ratio
2.622.683.501.261.671.87
Upgrade
Return on Equity (ROE)
0.66%1.18%2.69%22.93%34.51%24.35%
Upgrade
Return on Assets (ROA)
0.19%0.38%0.84%5.18%10.62%13.04%
Upgrade
Return on Capital (ROIC)
0.23%0.47%1.10%7.59%14.36%17.11%
Upgrade
Return on Capital Employed (ROCE)
0.40%0.80%1.40%10.20%19.60%28.10%
Upgrade
Earnings Yield
0.47%0.96%0.84%---
Upgrade
FCF Yield
-1.32%-3.27%-4.23%---
Upgrade
Dividend Yield
0.20%0.22%0.19%---
Upgrade
Payout Ratio
95.91%59.97%61.72%3.44%0.45%3.40%
Upgrade
Buyback Yield / Dilution
0.00%-2.71%-10.02%0.00%-0.13%0.12%
Upgrade
Total Shareholder Return
0.20%-2.49%-9.83%0.00%-0.13%0.12%
Upgrade
Updated Oct 24, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.